About Alderley Analytical
Alderley Analytical is a Healthcare company based in Stockport (United Kingdom) founded in 2013 by Elizabeth Thomas, Claire Wildgoose, Paul Holme, and Sally Hannam, and was acquired by Synexa Life Sciences in October 2024. Bioanalytical assays for drug development are developed and validated. Alderley Analytical has raised $869.35 thousand across 2 funding rounds from investors including Synexa Life Sciences, BioCity and Northern Powerhouse Investment Fund. The company has 41 employees. Its chief executive, as recorded, is Elizabeth Thomas. Alderley Analytical offers products and services including Preclinical Bioanalysis, Clinical Bioanalysis, GLP Regulatory Bioanalysis, Toxicokinetics, and Biomarker Analysis. Its focus areas include Biopharma Outsourcing, CRO, Diversified and Bioanalytical Services. Its legal entity is ALDERLEY ANALYTICAL LTD.
Company details
Alderley Analytical was established in 2013 as a Contract Research Organisation based in Stockport, United Kingdom. Bioanalytical services are provided for pre-clinical and clinical phases of drug development. Assays are developed and validated for small molecules, peptides, large molecules, and biomarkers. Analysis support is extended across all stages of the drug development process within the pharmaceutical sector.
- Headquarters Stockport, United Kingdom
- Employees 41
- Founders Elizabeth Thomas, Claire Wildgoose, Paul Holme, Sally Hannam
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website alderleyanalytical.com
- Social LinkedIn
- Acquired by Synexa Life Sciences (Oct 2024)
- Legal Name Alderley Analytical Ltd
- Date of Incorporation 27 Aug, 2013
- Jurisdiction MACCLESFIELD, CHESHIRE, ENGLAND
- Total Equity Funding$869.35K (USD)
in 2 rounds
- Latest Funding Round$400.49K (USD), Seed
Jun 2018
- InvestorsSynexa Life Sciences
& 3 more
- Employee Count41
- Acquired bySynexa Life Sciences
(Oct 2024)
Products & Services of Alderley Analytical
Alderley Analytical offers a comprehensive portfolio of products and services, including Preclinical Bioanalysis, Clinical Bioanalysis, GLP Regulatory Bioanalysis, Toxicokinetics, and Biomarker Analysis.
Supports drug discovery and safety testing for preclinical phases.
Handles immunogenicity and biomarker analysis in clinical development.
Ensures compliance with guidelines for regulatory bioanalysis.
Evaluates drug kinetics and safety in development programs.
Provides analysis for biomarkers in drug research and testing.
Funding Insights of Alderley Analytical
Alderley Analytical has successfully raised a total of $869.35K across 2 strategic funding rounds. The most recent funding activity was a Seed round of $400.49 thousand completed in June 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $869,352
- Total Rounds 2
- Last Round Seed — $400,485
- First Round $468,867
(Aug 2016)
- Investors Count 3
All 2 funding rounds of Alderley Analytical with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun 2018 | $400,485 | Seed | – | – | |
| Aug 2016 | $468,867 | Seed | – | – |
4 investors in total: 4 institutional.
Investors in Alderley Analytical
Alderley Analytical has secured backing from 4 investors, including venture fund investors. Prominent investors backing the company include Synexa Life Sciences, BioCity and Northern Powerhouse Investment Fund.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Private debt is extended to early-stage companies and SMEs. | npif.co.uk | Sheffield, United Kingdom | ||
Venture debt firm | thenorthwestfund.co.uk | Warrington, United Kingdom | ||
Life Science focused startup accelerator and incubator | 2002 | biocity.co.uk | Nottingham, United Kingdom | |
Provider of comprehensive analytical and advisory services, specializing in biomarker services | 2003 | synexagroup.com | Cape Town, South Africa |
Investor details for Alderley Analytical
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Alderley Analytical
4 people are tracked at Alderley Analytical (4 in leadership); the tracked headcount is 41.
| Name | Role | Group |
|---|---|---|
Elizabeth Thomas | Co-Founder & CEO | Leadership |
Claire Wildgoose | Co-Founder & Director | Leadership |
Paul Holme | Co-Founder & Director | Leadership |
Sally Hannam | Co-Founder & Director | Leadership |
Complete people profiles for Alderley Analytical
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Alderley Analytical
4 dated milestones of Alderley Analytical across 11 years, from founding to its latest funding, stage changes and deals.
- Founded Alderley Analytical is founded.
- Funding First funding round of $469K.
- Funding Latest funding round, Seed, of $400K.
- Exit Acquired by Synexa Life Sciences.
Web traffic of Alderley Analytical
The website of Alderley Analytical (alderleyanalytical.com) receives about 1.2K visits a month.
- Monthly visits1.2K
▲ 15% vs previous month
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Alderley Analytical
Complete news archive for Alderley Analytical
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Alderley Analytical
Alderley Analytical was founded in 2013 and raised its 1st funding round 3 years after it was founded.
Alderley Analytical is headquartered in Stockport, United Kingdom. It is registered at Stockport, Greater Manchester, United Kingdom.
Elizabeth Thomas is the CEO of Alderley Analytical, as recorded in our data. They have also founded this company.
Alderley Analytical is a funded company, having raised a total of $869.35K across 2 funding rounds to date. The company's 1st funding round was a Seed of $468.87K, raised on Aug 2016.
Alderley Analytical has 41 employees.
Alderley Analytical was established in 2013 as a Contract Research Organisation based in Stockport, United Kingdom. Bioanalytical services are provided for pre-clinical and clinical phases of drug development. Assays are developed and validated for small molecules, peptides, large molecules, and biomarkers. Analysis support is extended across all stages of the drug development process within the pharmaceutical sector.
Alderley Analytical offers Preclinical Bioanalysis, Clinical Bioanalysis, GLP Regulatory Bioanalysis, Toxicokinetics, and Biomarker Analysis.
Alderley Analytical has 4 investors. Key investors include Synexa Life Sciences, BioCity, Northern Powerhouse Investment Fund, and The North West Fund.
Alderley Analytical operates through Alderley Analytical Ltd.
Yes. Alderley Analytical was acquired by Synexa Life Sciences in October 2024.